Ardelyx
Commercializes IBSRELA and XPHOZAH from a gut-local NHE3 inhibition platform.
$3.84
After-hours close+0.03 (+0.75%)
At close$3.81(−0.26%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Oct 2026 | −$0.03 | — | — |
| Aug 2026 | −$0.07 | −$0.07 | −7.0% |
| Apr 2026 | −$0.13 | −$0.15 | −15.4% |
| Feb 2026 | $0.02 | $0.02 | 0.0% |
| Oct 2025 | −$0.06 | $0.00 | +93.3% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Oct 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Oct 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Oct 29, 2026 | −$0.03 | — | — | $129.2M | — | — |
| Aug 6, 2026 | −$0.07 | −$0.07 | −7.0% | $121.0M | $120.9M | −0.1% |
| Apr 30, 2026 | −$0.13 | −$0.15 | −15.4% | $92.8M | $94.5M | +1.8% |
| Feb 19, 2026 | $0.02 | $0.02 | 0.0% | $118.0M | $125.2M | +6.1% |
| Oct 30, 2025 | −$0.06 | $0.00 | +93.3% | $119.1M | $110.3M | −7.3% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Aug 4, 2025 | ||||||
| May 1, 2025 | ||||||
| Feb 20, 2025 | ||||||
| Oct 31, 2024 | ||||||
| Aug 1, 2024 | ||||||
| May 2, 2024 | ||||||
| Feb 22, 2024 | ||||||
| Oct 31, 2023 | ||||||
| Aug 2, 2023 | ||||||
| May 3, 2023 | ||||||
| Mar 2, 2023 | ||||||
| Nov 3, 2022 | ||||||
| Aug 4, 2022 | ||||||
| May 5, 2022 | ||||||
| Feb 28, 2022 | ||||||
| Nov 12, 2021 | ||||||
| Aug 13, 2021 | ||||||
| May 6, 2021 | ||||||
| Mar 8, 2021 | ||||||
| Nov 5, 2020 | ||||||
| Aug 6, 2020 | ||||||
| May 7, 2020 | ||||||
| Mar 6, 2020 | ||||||
| Nov 6, 2019 | ||||||
| Aug 9, 2019 | ||||||
| May 7, 2019 | ||||||
| Mar 6, 2019 | ||||||
| Nov 7, 2018 | ||||||
| Aug 7, 2018 | ||||||
| May 8, 2018 | ||||||
| Mar 14, 2018 | ||||||
| Nov 7, 2017 | ||||||
| Aug 9, 2017 | ||||||
| May 5, 2017 | ||||||
| Feb 17, 2017 | ||||||
| Nov 7, 2016 | ||||||
| Aug 8, 2016 | ||||||
| May 9, 2016 | ||||||
| Mar 4, 2016 | ||||||
| Nov 12, 2015 | ||||||
| Aug 12, 2015 | ||||||